학술논문
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction–associated steatohepatitis.
Document Type
Article
Author
Source
Hepatology Communications; Feb2024, Vol. 8 Issue 2, p1-8, 8p
Subject
Language
ISSN
2471254X